Related Experiment Video
Updated: Jul 11, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
On-treatment diastolic blood pressure and prognosis in systolic hypertension
Robert H Fagard1, Jan A Staessen, Lutgarde Thijs
1Hypertension and Cardiovascular Rehabilitation Unit, University of Leuven, B-3000 Leuven, Belgium. robert.fagard@uz.kuleuven.ac.be
Insights
Low diastolic blood pressure (BP) in older adults on antihypertensive treatment increases noncardiovascular mortality. Careful BP management is crucial, especially for those with coronary heart disease.
Area of Science:
- Cardiology
- Geriatrics
- Clinical Trials
Background:
- Investigating the potential harm of low diastolic blood pressure (BP) in older patients with systolic hypertension receiving antihypertensive treatment.
- Examining the association between on-treatment diastolic BP, mortality, and cardiovascular events.
Purpose of the Study:
- To assess the relationship between on-treatment diastolic BP and adverse outcomes in elderly patients with systolic hypertension.
- To determine the safety threshold for diastolic BP during antihypertensive therapy.
Main Methods:
- Prospective, placebo-controlled trial (Systolic Hypertension in Europe Trial) involving elderly patients with systolic hypertension.
- Randomization into a double-blind first phase, followed by active treatment for all patients.
- Multivariate Cox regression analysis to evaluate outcomes based on on-treatment diastolic BP during placebo and active treatment phases.
Main Results:
- Noncardiovascular mortality increased with lower diastolic BP in both placebo and active treatment groups.
- Low diastolic BP during active treatment was linked to an increased risk of cardiovascular events, particularly in patients with pre-existing coronary heart disease.
- Hazard ratios indicated a significant increase in mortality and events with decreasing diastolic BP levels.
Conclusions:
- Antihypertensive treatment intensification is supported to prevent cardiovascular events in older systolic hypertension patients until diastolic BP reaches 55 mm Hg.
- A cautious approach is advised for patients with coronary heart disease, suggesting diastolic BP should not be lowered below 70 mm Hg.
Background:
It has been suggested that low diastolic blood pressure (BP) while receiving antihypertensive treatment (hereinafter called on-treatment BP) is harmful in older patients with systolic hypertension. We examined the association between on-treatment diastolic BP, mortality, and cardiovascular events in the prospective placebo-controlled Systolic Hypertension in Europe Trial.
Methods:
Elderly patients with systolic hypertension were randomized into the double-blind first phase of the trial, after which all patients received active study drugs (phase 2). We assessed the relationship between outcome and on-treatment diastolic BP by use of multivariate Cox regression analysis during receipt of placebo (phase 1) and during active treatment (phases 1 and 2).
Results:
Rates of noncardiovascular mortality, cardiovascular mortality, and cardiovascular events were 11.1, 12.0, and 29.4, respectively, per 1000 patient-years with active treatment (n = 2358) and 11.9, 12.6, and 39.0, respectively, with placebo (n = 2225). Noncardiovascular mortality, but not cardiovascular mortality, increased with low diastolic BP with active treatment (P < .005) and with placebo (P < .05); for example, hazard ratios for lower diastolic BP, that is, 65 to 60 mm Hg, were, respectively, 1.15 (95% confidence interval, 1.00-1.31) and 1.28 (95% confidence interval, 1.03-1.59). Low diastolic BP with active treatment was associated with increased risk of cardiovascular events, but only in patients with coronary heart disease at baseline (P < .02; hazard ratio for BP 65-60 mm Hg, 1.17; 95% confidence interval, 0.98-1.38).
Conclusions:
These findings support the hypothesis that antihypertensive treatment can be intensified to prevent cardiovascular events when systolic BP is not under control in older patients with systolic hypertension, at least until diastolic BP reaches 55 mm Hg. However, a prudent approach is warranted in patients with concomitant coronary heart disease, in whom diastolic BP should probably not be lowered to less than 70 mm Hg.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Antihypertensive Drugs: Action of Diuretics
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure